ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,457,461 | -50.2% | 68,933 | -35.5% | 0.00% | -50.0% |
| Q2 2023 | $4,931,802 | +7.6% | 106,911 | -6.5% | 0.00% | 0.0% |
| Q1 2023 | $4,584,794 | +11.0% | 114,334 | +28.3% | 0.00% | 0.0% |
| Q4 2022 | $4,128,978 | +18.0% | 89,121 | +5.5% | 0.00% | +100.0% |
| Q3 2022 | $3,499,000 | -24.0% | 84,483 | +9.5% | 0.00% | -50.0% |
| Q2 2022 | $4,603,000 | -15.4% | 77,169 | +3.0% | 0.00% | 0.0% |
| Q1 2022 | $5,439,000 | -6.6% | 74,900 | +8.1% | 0.00% | 0.0% |
| Q4 2021 | $5,825,000 | -1.8% | 69,264 | +5.3% | 0.00% | 0.0% |
| Q3 2021 | $5,930,000 | +25.3% | 65,751 | +32.5% | 0.00% | 0.0% |
| Q2 2021 | $4,731,000 | -16.2% | 49,618 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $5,646,000 | -18.6% | 49,589 | -1.1% | 0.00% | -33.3% |
| Q4 2020 | $6,938,000 | +90.7% | 50,117 | +13.2% | 0.00% | +50.0% |
| Q3 2020 | $3,638,000 | -1.2% | 44,261 | -6.0% | 0.00% | 0.0% |
| Q2 2020 | $3,681,000 | +112.2% | 47,066 | +20.1% | 0.00% | +100.0% |
| Q1 2020 | $1,735,000 | -2.7% | 39,191 | -6.1% | 0.00% | 0.0% |
| Q4 2019 | $1,784,000 | +19.3% | 41,748 | +19.1% | 0.00% | 0.0% |
| Q3 2019 | $1,496,000 | -23.1% | 35,056 | +14.4% | 0.00% | 0.0% |
| Q2 2019 | $1,946,000 | -5.9% | 30,639 | +2.8% | 0.00% | 0.0% |
| Q1 2019 | $2,067,000 | +129.9% | 29,796 | +44.0% | 0.00% | 0.0% |
| Q4 2018 | $899,000 | -32.2% | 20,687 | +19.0% | 0.00% | 0.0% |
| Q3 2018 | $1,326,000 | +8.0% | 17,379 | +8.8% | 0.00% | 0.0% |
| Q2 2018 | $1,228,000 | +17.9% | 15,976 | -21.8% | 0.00% | 0.0% |
| Q1 2018 | $1,042,000 | -85.3% | 20,426 | -86.6% | 0.00% | -80.0% |
| Q4 2017 | $7,067,000 | +638.5% | 152,332 | +749.8% | 0.01% | +400.0% |
| Q3 2017 | $957,000 | +2.6% | 17,925 | +18.9% | 0.00% | 0.0% |
| Q2 2017 | $933,000 | +7.2% | 15,082 | +17.2% | 0.00% | 0.0% |
| Q1 2017 | $870,000 | -0.3% | 12,870 | +3.6% | 0.00% | 0.0% |
| Q4 2016 | $873,000 | +69.2% | 12,422 | +67.6% | 0.00% | 0.0% |
| Q3 2016 | $516,000 | +28.4% | 7,412 | -9.8% | 0.00% | – |
| Q2 2016 | $402,000 | -19.9% | 8,219 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $502,000 | -37.4% | 8,219 | +14.9% | 0.00% | 0.0% |
| Q4 2015 | $802,000 | +20.8% | 7,156 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $664,000 | +3.6% | 7,156 | +10.9% | 0.00% | 0.0% |
| Q2 2015 | $641,000 | +324.5% | 6,450 | +171.1% | 0.00% | – |
| Q1 2015 | $151,000 | +160.3% | 2,379 | +82.9% | 0.00% | – |
| Q4 2014 | $58,000 | -23.7% | 1,301 | 0.0% | 0.00% | – |
| Q3 2014 | $76,000 | – | 1,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |